AAX Biotech to attend BIO International Convention

We are excited to share that our CEO, Maria Lisa Knudsen, will be attending the BIO International Convention at the Boston Convention & Exhibition Center from June 16–19!

If you are exploring cutting-edge tools in epitope mapping or antibody engineering, come chat with us about Seqitope®, our high-resolution epitope mapping platform, and Opti-mAb®, our proprietary technology for stabilizing scFv molecules.

Let’s connect and explore how we can collaborate to accelerate biopharmaceutical innovation. See you in Boston!

Next
Next

AAX Biotech to attend Antibody Engineering and Therapeutics Europe 2025